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INTRODUCTION 
The resurgence of tuberculosis and outbreaks of 
multidrug-resistant Mycobacterium tuberculosis has in- 
creased the emphasis on rapid turn-round time for 
mycobacterial cultures and susceptibility testing for 
effective treatment and control of the disease [l-31. 
The two methods most commonly used in clinical 
laboratories for susceptibility testing of M. tuberculosis 
are the proportion method performed on Lowenstein- 
Jensen (LJ) egg medium and the Bactec TB 460 system 
(Becton Dickinson Microbiology System, Cockeys- 
ville, MD, USA) [4]. Because growth of colonies is 
necessary for interpretation, the agar proportion 
method requires 3 weeks of incubation. The Bactec 
TB system uses a broth medium containing radio- 
labeled palmitic acid substrate. Growth is detected by 
measuring 14C02 released during substrate utilization. 
With this method, results can be reported in as few as 
4 days, but it is still labor-intensive and expensive, and 
generates radioactive waste [5]. 
A new method, the Mycobacterial Growth 
Indicator Tube (MGIT) (Becton Dickinson Microbiol- 
ogy System, Sparks, MD, USA), uses a fluorescence 
quenching-based oxygen sensor to detect the growth 
of mycobacteria. Recently, the M G ~ T  system has been 
evaluated as a non-radiometric alternative to the Bactec 
TB system for the rapid growth and detection of 
mycobacteria [6]. The reliability of the MGIT tubes for 
susceptibility testing of M .  tuberculosis isolates to 
isoniazid and rifampin in comparison to those obtained 
by the Bactec system has been evaluated [7]. We report 
the results obtained by using the MGIT system to test 
the susceptibilities of M.  tuberculosis clinical isolates to 
streptomycin, isoniazid, rifampin and ethambutol in 
comparison to those obtained with the Bactec system. 
MATERIALS AND METHODS 
Strains 
Fifty-two clinical isolates, including 22 strains resistant 
to one drug and 13 multiresistant, were tested in the 
MGIT system; the results were compared with those 
obtained with the radiometric method. Twenty-four 
strains were obtained from frozen clinical cultures (iso- 
lated during 1993-95) and 28 fresh clinical cultures 
from clinical specimens sent to our laboratory during 
the first 6 months of 1997. M. tuberculosis H37rv, sus- 
ceptible to all antimicrobials, and four strains of M.  
tuberculosis, ATCC 35838, 35822, 35820 and 35837, 
resistant to each one of the antimicrobials tested, were 
included as control strains. All isolates and control 
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strains were subcultured on LJ slants and incubated for 
2-3 weeks prior to testing. 
Susceptibility testing 
lnoculum preparation 
Colonies from LJ slants were transferred to a tube 
containing Middlebrook 7H9 broth and five to eight 
sterile glass beads. Tubes were vigorously agitated on a 
vortex mixer and clumps were allowed to settle for 
20 min. The supernatant was transferred to a sterile tube 
and clumps were again allowed to settle for 15 min. 
This supernatant was removed and adjusted with 
Middlebrook 7H9 broth to equal the density of a 0.5 
McFarland standard for use as the standard inoculum in 
the Bactec TB 460 and MGIT systems and adjusted to 
equal the density of 1.0 McFarland for use as the 
standard inoculum for the proportion method [7]. 
MGlT procedure 
Susceptibility testing was performed according to the 
protocol provided by the manufacturer. Tubes were 
prepared by adding 0.5 mL of MGIT OADC enrich- 
ment (Becton Dickinson) and 0.5 mL of a 1:5 dilution 
(with sterile saline) of the inoculum prepared as 
described previously. For each sample, four drug- 
containing MGITS and one control tube without drug 
were inoculated. Antimycobacterial drugs were 
adjusted in the MGITS to final concentrations of 
0.8 mg/L for streptomycin, 0.1 mg/L for isoniazid, 
1 mg/L for rifampin and 3.5 mg/L for ethambutol, as 
recommended by the manufacturer. The tubes were 
incubated at 37°C and were examined daily for 
fluorescence with a 365-nm W light. The results were 
interpreted only after the growth control tube 
fluoresced. A test result was considered to indicate 
resistance if the drug-containing tube fluoresced within 
2 days of the growth control tube fluorescing [7]. 
Bactec TB procedure 
Control Bactec 12B vials contained 0.1 mL of a 1:lOO 
dilution of the inoculum. Antimycobacterial drugs 
were adjusted in the Bactec 12B vials to final concen- 
trations of 2.0 mg/L for streptomycin, 0.1 mg/L for 
isoniazid, 2 mg/L for rifampin and 2.5 mg/L for 
ethambutol. Vials were read on the Bactec 460 daily, 
starting on day 3 after inoculation, until the growth 
index of the control vial reached 30. An isolate was 
defined as resistant if the change in the growth index 
(AGI) of the drug-containing vial was greater than the 
AGI of the drug-free control [4]. 
The differences between mean time (&om the day 
of inoculation) to test results for the MGIT and 
BACTEC systems were compared by the Student t-test. 
When results from the MGIT and Bactec systems 
disagreed, strains were tested by the indn-ect proportion 
method on LJ slants (bioMerieux Espaiia, SA, 
Barcelona, Spain) at concentrations of 4 and 10 mg/L 
for streptomycin, 0.2 and 0.1 mg/L for isoniazid, 20 
and 40mg/L for rifampin and 2 and 3mg/L for 
ethambutol [8]. 
Analysis of the data 
The values for sensitivity (ability to detect true 
resistance), specificity (ability to detect true suscept- 
ibility) and efficiency (ratio between the number of 
correct results and the total number of results), and 
predictive values for resistance (PVR, the ratio of true 
resistances to total resistance) and for susceptibility 
(PVS, rate of true susceptibility to total susceptibhty), 
were calculated according to Laszlo et al [9] in order to 
interpret the data. 
RESULTS 
Comparative results of drug susceptibility testing by the 
MGIT and Bactec 460 systems are summarized in Table 
1. Streptomycin results agreed for 48 of the 52 isolates 
(92%). The method of proportion agreed with MGIT 
in two cases, and agreed with the Bactec system in the 
other two cases (Table 1). On repeat testing in the 
MGIT system with a similar streptomycin final concen- 
tration 2 mg/L to that used in the Bactec system, all 
four strains became susceptible to streptomycin, and 
isoniazid results agreed for 49 of the 52 isolates (94%). 
The method of proportion agreed with MGIT in two 
cases (both susceptible strains), and agreed with the 
Bactec system in one case. On repeat testing, one of the 
strains became resistant, but the other two strains 
Table 1 Analysis of susceptible and resistant M. tuberculosis isolated by the MGIT and Bactec 460 systems: analysis of the 
discrepant results between the MGIT and the Bactec systems in comparison with those obtained by the LJ proportion method 
Drug MGIT/Bactec S MGIT/Bactec R MGIT R/Bactec S MGIT S/Bactec R LJ S LJ R 
Streptomycin 47 1 4 0 2 2 
Isoniazid 23 26 1 2 2 1 
Rifampin 33 18 0 1 1 0 
Ethambutol 50 2 0 0 0 0 
S, susceptible; R, resistant. 
Concise  C o m m u n i c a t i o n s  2 2 9  
Table 2 Comparative evaluation among the results for the four drugs obtained with the MGIT system with those obtained 
with the Bactec system and the LJ proportion method 
Bactec system / Proportion method 
Ilrug Sensitivity Specificity Efficiency PVR PVS 
Streptomycin 1 uo/100 92/100 92/100 20/100 100/100 
Rifampin 95/100 97/100 98/100 100/100 97/ion 
Isoniazid 93/96 96/100 94/98 96/100 92/96 
Ethambutol 100/100 100/100 100/100 100/100 100/100 
PVK, predictive value of resistance; PVS, predictive value of susceptibility. 
remained susceptible. However, among these three 
isoniazid-resistant strains, one strain had a ka tG  gene 
mutation and the other two strains had i n h A  gene 
mutations [I 01. Rifampin results agreed for 5 1 of the 
52 isolates (98%), and disagreed for one isolate in which 
the result of the method of proportion agreed with that 
of the MGIT, although this isolate has a rpoB gene 
mutation [ l l ] .  Ethambutol results agreed (100%) for all 
isolates, 50 susceptible strains and two resistant strains. 
The sensitivity, specificity and efficiency values [9] 
when the MCIT results are compared with those 
obtained with the Bactec system and the proportion 
method for the four antimicrobials are summarized in 
Table 2. 
The mean time (*standard error of the mean) 
from inoculation to results for MGIT was 5.4k2.5 
(range, 2-10) days for streptomycin, 5.6k2.0 (range, 
2-11) days for isoniazid, 5.5k2.1 (range, 2-11) days 
for rifampin and 5.452.0 (range, 2-10) days €or 
ethambutol, compared to a mean of 6.7k1.7 days 
for all drugs with the Bactec system (p<0.001). 
DISCUSSION 
In our study, the turn-round time for the MGIT 
system was 4-9 days (median 6). which is similar to 
preliminary results previously reported [7,12], 
compared with 5-12 days for Bactec (median 8). The 
lack of one unique internationally accepted lab- 
oratory methodology for susceptibility testing of M.  
tuberculosis makes it very difficult to compare the 
results obtained with different testing methods. We 
found a better correlation between MGIT and the 
proportion method on LJ than with the Bactec 460 
method when testing streptomycin, rifampin and 
ethambutol, but a poorer correlation when testing 
isoniazid. Overall, these results agreed with those 
obtained by Laszlo et a1 [9], except for those of 
isoniazid. However, three resistant strains (two 
isoniazid-resistant and one rifampin-resistant) con- 
firmed by molecular methods [10,11] were detected 
only in the Bactec system, and had been missed by 
the former systems. Two isoniazid-resistant isolates 
were detected by the Bactec system after 15 days of 
incubation because the increase in GI was very slow. 
These strains might have been detected by the MCIT 
system with longer incubation. The correlation 
between MGIT and Bactec test results for testing 
susceptibility to rifampin was not 100% as previously 
reported [7,13]. Results for 51 of 52 isolates agreed; 
the MGIT system detected 18 of 19 rifampin-resistant 
isolates included in this study. 
In contrast, for testing susceptibility to strepto- 
mycin, Palaci et a1 [14] found 100% correlation 
between MGIT and the indirect proportion method on 
LJ using a final concentration of 2 mg/L. Our results 
agreed with those obtained by Bergmann et al [12], and 
when repeat testing was performed by us with that 
concentration, we also found 100% agreement between 
the MGIT and Bactec systems. Again, Laszlo et a1 [9] 
found discordant results when testing streptomycin, as 
we did; however, no discrepant results were found by 
us when testing ethambutol, probably due to the small 
number of resistant strains tested in our study. It is 
noticeable that the results obtained by molecular 
methods do not always correlate with those obtained 
by the different microbiological methods, suggesting 
that these molecular methods should be included as a 
part of the evaluation of the different drug susceptibility 
testing of hf. tubevculosis. 
Too few data have been collected to determine the 
critical concentration of drugs required for suscept- 
ibility testing using the MGIT system; however, the 
need to use a critical concentration different from that 
used in the standard method would not be surprising, 
given the unique detection system and the test media. 
The reading of the signal and its interpretation as 
‘positive’ or ‘negative’ remains subjective and may vary 
from person to person, so a scale for the interpretation 
of the fluorescence signal should be included in the 
MGIT system. 
In summary, the MGIT system appears to be an 
acceptable alternative to the radiometric Bactec 
method for rapid and reliable susceptibility testing of 
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M.  tuberculosis. Additional studies with all four drugs 
should be performed to confirm our results as well as 
to determine the critical concentration of drugs re- 
quired, especially those of streptomycin and rifampin. 
If an automated system incorporating MGIT technology 
is made available, it may further enhance the 
performance. 
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Patients undergoing renal dialysis are at increased 
risk of hepatitis C virus (HCV) infection, depending 
on the duration of treatment, extended exposure to 
transfusion and possible nosocomial transmission. The 
reported [I] incidence of HCV infection in dialysis 
units in southern Europe, Japan and the USA ranges 
from 10% to 30%, while in northern Europe the 
incidence is lower, ranging from 1% to 9%. 
Information about HCV infections in the general 
African population is scant, with reported prevalence 
rates varying greatly in different countries, &om more 
than 10% in the pygmy population in Cameroon to 
0-1.5% in South Africa. Socio-economic factors as 
well as cultural tradition (such as cosmetic tattooing) are 
likely to be relevant to the observed variation. To our 
knowledge, no data are available for Sub-Saharan Africa 
